ISCARNA Therapeutics
Cellular reprogramming, reimagined
Developing first-in-class oligonucleotides for the treatment of complex age-related disease
To view the technology behind ISCARNA's innovative therapeutic pipeline, please click here.
A spin-out from
Proudly designed by 101 Data Solutions
© 2026 by ISCARNA.